Skip to main content
Hidayatullah Munshi, MD, Oncology, Chicago, IL

Hidayatullah G Munshi MD

Gastrointestinal Cancer, Hematologic Oncology


Professor of Medicine-Hematology/Oncology, Northwestern University Medical School

Join to View Full Profile
  • 303 E Superior AveLurie 3-117Chicago, IL 60611

  • Phone+1 312-503-2301

Dr. Munshi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2000 - 2002
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1996 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1996

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2000 - 2026
  • MI State Medical License
    MI State Medical License 1999 - 2003
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2012

Publications & Presentations

PubMed

Press Mentions

  • Combination Therapy May Improve Treatment Response in Pancreatic Cancer
    Combination Therapy May Improve Treatment Response in Pancreatic CancerOctober 10th, 2024
  • Northwestern Selected as Home for Journal of Clinical Investigation; McNally to Serve as Editor-in-Chief
    Northwestern Selected as Home for Journal of Clinical Investigation; McNally to Serve as Editor-in-ChiefDecember 14th, 2021
  • Loss of Sirt2 Increases and Prolongs a Caerulein-Induced Pancreatitis Permissive Phenotype and Induces Spontaneous Oncogenic Kras Mutations in Mice
    Loss of Sirt2 Increases and Prolongs a Caerulein-Induced Pancreatitis Permissive Phenotype and Induces Spontaneous Oncogenic Kras Mutations in MiceNovember 7th, 2018

Grant Support

  • NU-TRIHO (Northwestern University Translational Research in Hematology-Oncology) Training ProgramNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
  • Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic CancerNORTHWESTERN UNIVERSITY AT CHICAGO2022–2027
  • Role of MNK kinase pathway in regulating tumor immune microenvironment in pancreatic cancerJESSE BROWN VA MEDICAL CENTER2022–2026
  • Targeting Stromal Reaction In Pancreatic Cancer To Overcome Chemo-ResistanceVeterans Affairs2012
  • Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer InvasionNational Cancer Institute2011–2012
  • Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer InvasionNational Cancer Institute2008–2010
  • Cadherin-Mediated Regulation Of MMPS In Oral CancerNational Cancer Institute2003–2007

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: